Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Male infertility and Non-obstructive azoospermia. 7 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 1 | Male infertility |
MSH4 encodes mutS homolog 4 (936 aa). Involved in meiotic recombination. Required for reciprocal recombination and proper segregation of homologous chromosomes at meiosis Highest expression in Testis (6.4 TPM) and Brain Cerebellum (2.5 TPM).
Spermatogenic failure 2 is associated with mutations in the MSH4 gene on chromosome 1.
The MSH4 protein participates in Resolution of meiotic holliday junction, Formation of meiotic holliday junction, and Meiotic recombination pathways.
MSH4 is classified as a druggable target with score 0.0.
Genetic testing for MSH4 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for spermatogenic failure 2 has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for spermatogenic failure 2.
41 publications have been identified in PubMed for spermatogenic failure 2. Research spans Basic Science / Preclinical (59%), Review / Meta-Analysis (22%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 24 | 59% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 3:29 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
9 |
22% |
Disease patterns and progression | 3 | 7% |
Testing and diagnosis research | 2 | 5% |
Clinical study results | 2 | 5% |
Other research | 1 | 2% |
Tian Y (2026). [PMID: 41751410](https://pubmed.ncbi.nlm.nih.gov/41751410/). *Current issues in molecular biology*. [Basic Science / Preclinical]
Jeanne F (2026). [PMID: 41724374](https://pubmed.ncbi.nlm.nih.gov/41724374/). *Journal of proteomics*. [Basic Science / Preclinical]
Wang X (2026). [PMID: 41555377](https://pubmed.ncbi.nlm.nih.gov/41555377/). *Reproductive biology and endocrinology : RB&E*. [Review / Meta-Analysis]
Zhou L (2026). [PMID: 41714893](https://pubmed.ncbi.nlm.nih.gov/41714893/). *The world journal of men's health*. [Review / Meta-Analysis]
Atkins GR (2026). [PMID: 41756962](https://pubmed.ncbi.nlm.nih.gov/41756962/). *bioRxiv : the preprint server for biology*. [Clinical Trial Publication]
Cheng J (2026). [PMID: 41745628](https://pubmed.ncbi.nlm.nih.gov/41745628/). *Metabolites*. [Basic Science / Preclinical]
Zhu Y (2026). [PMID: 41493470](https://pubmed.ncbi.nlm.nih.gov/41493470/). *Cellular and molecular life sciences : CMLS*. [Basic Science / Preclinical]
Kelley LH (2026). [PMID: 41109472](https://pubmed.ncbi.nlm.nih.gov/41109472/). *Developmental biology*. [Basic Science / Preclinical]
Alsenousy AHA (2026). [PMID: 41724789](https://pubmed.ncbi.nlm.nih.gov/41724789/). *Scientific reports*. [Basic Science / Preclinical]
Lu Y (2026). [PMID: 41750650](https://pubmed.ncbi.nlm.nih.gov/41750650/). *Antioxidants (Basel, Switzerland)*. [Basic Science / Preclinical]